Anika Therapeutics reported $-3381000 in Operating Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbott ABT:US $ 2388M 524M
Acorda Therapeutics ACOR:US $ -13.92M 2.79M
Agenus AGEN:US $ -44.56M 9.1M
Agios Pharmaceuticals AGIO:US $ -94.94M 3.5M
Anika Therapeutics ANIK:US $ -3.38M 0.17M
Arrowhead Research ARWR:US $ -72909000 114.46M
Chemocentryx CCXI:US $ -31.57M 6.66M
Clovis Oncology CLVS:US $ -59.38M 9.02M
Enanta Pharmaceuticals ENTA:US $ -32.54M 1.31M
Halozyme Therapeutics HALO:US $ 34.06M 41.61M
Heron Therapeutics HRTX:US $ -49.5M 13.42M
Immunogen IMGN:US $ -61.05M 38.2M
Insmed INSM:US $ -88316000 1.52M
Integra Lifesciences IART:US $ 61.06M 13.6M
Intrexon XON:US $ -24.16M 6.27M
Johnson & Johnson JNJ:US $ 5840M 22M
Karyopharm Therapeutics KPTI:US $ -42908000 8.32M
Ligand Pharmaceuticals LGND:US $ -0.47M 7.34M
Macrogenics MGNX:US $ -41808000 24.83M
Merit Medical Systems MMSI:US $ 23.26M 8.02M
Peregrine Pharmaceuticals PPHM:US $ 1.07M 2.2M
Rigel Pharmaceuticals RIGL:US $ -12.96M 13.3M
Sangamo Biosciences SGMO:US $ -45.73M 0.47M
Stryker SYK:US $ 772M 325M
Surmodics SRDX:US $ -7.14M 2.24M
Veracyte VCYT:US $ -10.73M 4.51M
Xencor XNCR:US $ -28M 54.47M
Zimmer Biomet Holdings Inc ZBH:US $ 280.9M 82.5M